Parkinson's Disease Clinical Trial
Official title:
Immediate Effects of Treadmill Gait Training Combined With Cognitive Tasks in Individuals With Parkinson's Disease: Randomized Controlled Trial
Verified date | November 2012 |
Source | Universidade Federal do Rio Grande do Norte |
Contact | n/a |
Is FDA regulated | No |
Health authority | Brazil: Ethics Committee |
Study type | Interventional |
Treadmill gait training combined with cognitive tasks in Parkinson's disease.
Status | Completed |
Enrollment | 22 |
Est. completion date | September 2012 |
Est. primary completion date | September 2012 |
Accepts healthy volunteers | No |
Gender | Both |
Age group | 45 Years to 70 Years |
Eligibility |
Inclusion Criteria: - Diagnosis of idiopathic PD by a neurologist and confirmed by complementary examinations; - Degree of disease progression equivalent to stages 2 to 3 of the Modified Hoehn and Yahr Scale; - Regular use of antiparkinson medication, exhibiting stable response; able to walk independently without ortheses or other assistive devices; - Absence of brain stimulation surgery; absence of cardiovascular, respiratory and musculoskeletal diseases that could compromise performance during assessment and training; - Absence of other neurological disorders; - Absence of non-corrected visual or auditory disturbances; - Be able to understand verbal instructions; being literate; - Give their written informed consent. Exclusion Criteria: - Blood pressure above 140X90 mmHg before the intervention (values referring to the first stage of hypertension); - Heart rate above the submaximal value, calculated by the formula 0.75 x (220-age), during the intervention; - Feeling nauseous or experiencing persistent acute pain during the exercises; - Voluntarily abandoning the study. |
Allocation: Randomized, Intervention Model: Parallel Assignment, Masking: Single Blind (Investigator), Primary Purpose: Treatment
Country | Name | City | State |
---|---|---|---|
Brazil | Federal University of Rio Grande do Norte | Natal | Rio Grande do Norte |
Lead Sponsor | Collaborator |
---|---|
Universidade Federal do Rio Grande do Norte | Conselho Nacional de Desenvolvimento Científico e Tecnológico |
Brazil,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Changes in kinematic gait parameters after treadmill training | The treadmill training was realized for 20 minutes. Immediately after treadmill training, kinematic gait data were captured by Qualisys Track Manager software and exported to Visual 3D, to reconstruct the segments and create a biomechanical model. It was carried out in two stages: static and dynamic collection. The primary outcome measure was the kinematic variables at the phase post training on treadmill. The kinematic variables include: speed (m/s), cadence (steps/min), stride length (m), step length (m) and angular displacement (ยบ). | Immediately after gait training on treadmill. | No |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT02915848 -
Long-term Stability of LFP Recorded From the STN and the Effects of DBS
|
||
Recruiting |
NCT03648905 -
Clinical Laboratory Evaluation of Chronic Autonomic Failure
|
||
Terminated |
NCT02688465 -
Effect of an Apomorphine Pump on the Quality of Sleep in Parkinson's Disease Patients (POMPRENELLE).
|
Phase 4 | |
Completed |
NCT05040048 -
Taxonomy of Neurodegenerative Diseases : Observational Study in Alzheimer's Disease and Parkinson's Disease
|
||
Active, not recruiting |
NCT04006210 -
Efficacy, Safety and Tolerability Study of ND0612 vs. Oral Immediate Release Levodopa/Carbidopa (IR-LD/CD) in Subjects With Parkinson's Disease Experiencing Motor Fluctuations
|
Phase 3 | |
Completed |
NCT02562768 -
A Study of LY3154207 in Healthy Participants and Participants With Parkinson's Disease
|
Phase 1 | |
Completed |
NCT00105508 -
Sarizotan HC1 in Patients With Parkinson's Disease Suffering From Treatment-associated Dyskinesia
|
Phase 3 | |
Completed |
NCT00105521 -
Sarizotan in Participants With Parkinson's Disease Suffering From Treatment Associated Dyskinesia
|
Phase 3 | |
Recruiting |
NCT06002581 -
Repetitive Transcranial Magnetic Stimulation(rTMS) Regulating Slow-wave to Delay the Progression of Parkinson's Disease
|
N/A | |
Completed |
NCT02236260 -
Evaluation of the Benefit Provided by Acupuncture During a Surgery of Deep Brain Stimulation
|
N/A | |
Completed |
NCT00529724 -
Body Weight Gain, Parkinson, Subthalamic Stimulation
|
Phase 2 | |
Active, not recruiting |
NCT05699460 -
Pre-Gene Therapy Study in Parkinson's Disease and Multiple System Atrophy
|
||
Completed |
NCT03703570 -
A Study of KW-6356 in Patients With Parkinson's Disease on Treatment With Levodopa-containing Preparations
|
Phase 2 | |
Completed |
NCT03462680 -
GPR109A and Parkinson's Disease: Role of Niacin in Outcome Measures
|
N/A | |
Completed |
NCT02837172 -
Diagnosis of PD and PD Progression Using DWI
|
||
Not yet recruiting |
NCT04046276 -
Intensity of Aerobic Training and Neuroprotection in Parkinson's Disease
|
N/A | |
Recruiting |
NCT02952391 -
Assessing Cholinergic Innervation in Parkinson's Disease Using the PET Imaging Marker [18F]Fluoroethoxybenzovesamicol
|
N/A | |
Active, not recruiting |
NCT02937324 -
The CloudUPDRS Smartphone Software in Parkinson's Study.
|
N/A | |
Completed |
NCT02939391 -
A Study of KW-6356 in Subjects With Early Parkinson's Disease
|
Phase 2 | |
Completed |
NCT02874274 -
Vaccination Uptake (VAX) in PD
|
N/A |